Mitochondrial ROS Production Protects the Intestine from Inflammation through Functional M2 Macrophage Polarization

Laura Formentini1, Fulvio Santacatterina1, Cristina Núñez de Arenas1

  • 1Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), 28049 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, 28049 Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Cell Reports
|May 13, 2017
PubMed

Insights

Partial inhibition of mitochondrial ATP synthase in mice triggers an anti-inflammatory response via mitochondrial reactive oxygen species (mtROS) and NFκB activation, offering a potential therapeutic target for inflammatory diseases.

Area of Science:

  • Cellular Physiology
  • Immunology
  • Mitochondrial Biology

Background:

  • Mitochondria act as crucial signaling hubs in cellular physiology.
  • Mitochondrial dysfunction is implicated in the pathogenesis of inflammatory diseases.

Purpose of the Study:

  • To investigate the role of mitochondrial ATP synthase inhibition in modulating inflammatory responses.
  • To explore the underlying mechanisms involving mitochondrial reactive oxygen species (mtROS) and NFκB signaling.

Main Methods:

  • Utilized transgenic mice with partial inhibition of mitochondrial ATP synthase.
  • Induced colitis using DSS (dextran sodium sulfate) to model inflammatory bowel disease.
  • Administered MitoQ, a mitochondria-targeted antioxidant, to assess the role of mtROS.

Main Results:

  • Partial ATP synthase inhibition induced an anti-inflammatory phenotype in mice challenged with DSS-induced colitis.
  • This phenotype was mediated by NFκB activation through mtROS, promoting M2 macrophage polarization.
  • Inhibition of mtROS with MitoQ abolished the protective effects, highlighting the critical role of mtROS.

Conclusions:

  • Mitochondrial signaling is integral to the innate immune system.
  • Partial inhibition of mitochondrial ATP synthase confers protection against experimental colitis.
  • Mitochondrial ATP synthase represents a potential therapeutic target for inflammatory diseases.